TEM

TEM

Tempus Soars: Q3 2026 Results Showcase Dazzling Growth and Strategic Partnerships

Tempus, a leading healthcare technology company, has released its Q3 2026 financial results, showcasing an impressive quarter of growth and strategic partnerships. The company's diagnostics business delivered $303.5 million in revenue, an increase of 20% year-over-year, driven by oncology revenues, which grew 28%, with volume growth of

TEM

Tempus AI Delivers Exceptional Q2 2026 Results, Bolstered by Strong Growth in Diagnostics Business and Significant Milestones in Data and Modeling Capabilities

Tempus AI, a leading provider of artificial intelligence and machine learning solutions for the healthcare industry, today reported exceptional second quarter (Q2) 2026 results, driven by strong growth in its diagnostics business and significant milestones in its data and modeling capabilities. In a conference call to discuss its Q2 2026